arrow
A

Agnieszka Tomaszewska

Medical University of Warsaw
H指数:14
被引数:890

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term Results of Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Real-life Data of 15- and 20-year Survivals from a Single Center

异基因造血细胞移植(allo-HCT)的长期结果:单中心15年和20年生存率的真实世界数据

2026-09-220
OAAI
Complications of Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide—A Prospective Study on Behalf of the EBMT Transplant Complications Working Party

haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide的并发症——EBMT移植并发症工作组发起的一项前瞻性研究

2025-12-180
OAAI
miR-302d-3p expression and genotype are associated with CMV replication after allogeneic haematopoietic stem cell transplantation

miR-302d-3p的表达和基因型与异基因造血干细胞移植后的CMV复制相关

2025-10-080
OAAI
ILT-2 and ILT-4 expression and donor genotype as factors associated with HSCT outcome

ILT-2和ILT-4的表达以及供者基因型作为与HSCT结局相关的因素

2025-10-020
PRE
Significance of HLA-E and its two NKG2 receptors in development of complications after allogeneic transplantation of hematopoietic stem cells

Hla-e及其两种NKG2受体在异基因造血干细胞移植后并发症发生中的意义

2023-10-132
OAAI
Potent but transient immunosuppression of T-cells is a general feature of CD71+ erythroid cells

T细胞的有效但短暂的免疫抑制是CD71红系细胞的一般特征

2021-12-1020
OAAI
Prevalence of hypogammaglobulinemia and its management with subcutaneous immunoglobulin supplementation in patients after allogeneic hematopoietic stem cell transplantation-a single-center analysis
2021-09-033
OAAI
Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies
2021-02-023
OAAI
Fecal microbiota transplantation in patients with acute and chronic graft-versus-host disease-spectrum of responses and safety profile. Results from a prospective, multicenter study
2021-01-1321
OAAI
Real-world prognostic factors in autotransplanted multiple myeloma patients with severe renal impairment: study of the Polish Myeloma Study Group
2020-04-180
OAAI
HLA-inferred extended haplotype disparity level is more relevant than the level of HLA mismatch alone for the patients survival and GvHD in T cell-replate hematopoietic stem cell transplantation from unrelated donor
2018-06-0111
PREAI
Beneficial effect of the CXCL12-3′A variant for patients undergoing hematopoietic stem cell transplantation from unrelated donors

CXCL12-3 'a变体对接受无关供者造血干细胞移植的患者的有益作用

2015-12-014
PREAI
Donor NK cell licensing in control of malignancy in hematopoietic stem cell transplant recipients
2014-08-2723
PREAI
Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus-Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

儿童和成人造血干细胞移植后爱泼斯坦-巴尔病毒相关淋巴组织增生性疾病的基于利妥昔单抗的治疗反应和危险因素分析: 来自欧洲血液和骨髓移植小组传染病工作组的一项研究

2013-06-13189
OAAI